Evaluation of plasma levels of tumour necrosis factor alpha and interleukin-6 as rejection markers in a cohort of 142 heart-grafted patients followed by endomyocardial biopsy

European Heart Journal
A N AbdallahA Iron

Abstract

The rejection reaction after cell or organ transplantation has to be detected as early as possible in order to conduct optimal immunosuppressive treatment. Among the numerous events leading to rejection, cytokine production, especially of tumour necrosis factor alpha, is particularly important. Interleukin-6 and tumour necrosis factor alpha were investigated in 142 heart-grafted patients in order to define an early peripheral non-invasive marker of an acute rejection that could fit well with myocardial biopsy results. Cytokines were immunoenzymatically measured in blood specimens collected on the day of the endomyocardial biopsy. The values were compared to the grade of heart graft rejection established according to pathological criteria. Plasma interleukin-6 and especially tumour necrosis factor alpha determined on the day of the rejection diagnosis were significantly increased in the patient sample with moderate or severe rejection when compared with mean values of interleukin-6 and tumour necrosis factor alpha in the patient sample without rejection or with mild rejection (P = 0.04 and 0.001 respectively). Because high levels of tumour necrosis factor alpha may appear before histological signs, this biological marker could b...Continue Reading

Citations

Aug 17, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Tsuneo OgawaAdolfo J de Bold
Aug 16, 2002·Transplant Immunology·Mario C DengSilviu Itescu
Oct 31, 2001·Clinical Transplantation·C M AlvarezL F García
Dec 27, 2005·Transplantation·Kate R WyburnSteven J Chadban
Jul 26, 2012·Transplantation·Ajda Tahereh Rowshani, Elly Johanna Francisca Vereyken
Sep 1, 2005·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Andreas Pascher, Jochen Klupp
Jul 14, 2010·Seminars in Nephrology·Steven J ChadbanJeremy Hughes
Jun 5, 2007·Heart Failure Clinics·Thomas J DenglerHugo A Katus
Feb 6, 2007·Transplantation Proceedings·D G HealyA E Wood
Aug 29, 2009·Clinical Transplantation·L Martínez-DolzA Salvador
May 26, 2005·International Immunopharmacology·Tatsuya SasakawaSeitaro Mutoh
Mar 7, 2015·Life Sciences·Andrea M KemterJudith Alferink
May 16, 2009·Journal of the American College of Cardiology·Scott R AuerbachSeema Mital
Jun 30, 2014·Cellular Immunology·Tony KwanSteven J Chadban
Aug 24, 1999·European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics·A N AbdallahA Iron
Mar 26, 1998·The American Journal of Cardiology·A K AndreassenP Aukrust
Jun 9, 2021·Current Transplantation Reports·Cynthia L Miller, Joren C Madsen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.